Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma

Table 3 Relationship between proliferating cell nuclear antigen and E-cadherin expression and clinicopathological characteristics of gastric cancer patients

Clinicopathological characteristic	No. of cases	PCNA		E-cadherin
		Positive	P value	Positive	P value
Gender			0.073		0.340
Male	45	37		16
Female	21	13		5
Age (yr)			0.319		0.140
≥ 60	40	32		10
< 60	26	18		11
Lymph node metastasis			0.039		0.000
Yes	42	36		7
Non	24	14		14
Degree of differentiation			0.278		0.065
Medium and low differentiation	42	30		10
High differentiation	24	20		11
T stage			0.003		0.568
T1/T2	25	14		9
T3/T4	41	36		12

PCNA: Proliferating cell nuclear antigen.